UHS
Universal Health ServicesPrevious close
176.05
Change
−0.56 / −0.32%
P/E (TTM) ?
7.1
Market Cap
$10.3B
1M
+1.03%
S&P 500 −0.91% over same period
Volume / Avg Volume
582K / 739K
0.79× average
Latest earnings analysisFY2026 Q2Reported 2026-07-28
UHS Q2 FY2026: revenue up 8.3%, EPS $5.98, guidance trimmed
UHS grew revenue 8.3% to $4.638 billion and diluted EPS 10.1% to $5.98, but missed the $6.02 consensus and trimmed full-year adjusted guidance. Read the quarter knowing that a $72 million net Florida Medicaid benefit inflated it, and that management assumes no repeat. Volumes rose on both sides of the business; the outlook did not.
Read the full analysis →Revenue$4.64BYoY +8.30%
EPS (non-GAAP)$5.98Missest. $6.02
Next-quarter revenue guidance$18.63B ±0.7%YoY +301.70%
Next-day move+1.17%
Recent Earnings
Click to read the FinDog analysis| Period | Reported | Revenue | Analysis |
|---|---|---|---|
| FY2026 Q2 Quarter ended 2026-06 | 2026-07-28 | $4.6B | Read analysis → |
| FY2026 Q1 Quarter ended 2026-03 | 2026-04-28 | $4.5B | Pending |
| FY2025 Q4 Quarter ended 2025-12 | 2026-02-25 | $17.4B | Pending |
| FY2025 Q3 Quarter ended 2025-09 | 2025-10-28 | $4.5B | Pending |
| FY2025 Q2 Quarter ended 2025-06 | 2025-07-29 | $4.3B | Pending |
| FY2025 Q1 Quarter ended 2025-03 | 2025-04-29 | $4.1B | Pending |
Decision Panel
Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market dataValuation
P/E is at percentile 9 of its 5-year rangeCheap
5-year range 6.6 – 17.3 · Median 11.2
Last 4 quarters: $1.1B in buybacks + $49.6M in dividends, 10.86% of market cap combined
P/E (TTM)
7.1
P/B
1.4
P/S
0.6
Dividend Yield
0.58%
Earnings Reaction
Over the last 6 reports, the stock moved ±3.9% on average on the first trading day after, rising 5 times
Most recent +1.17%
Volatility & Correlation
1-year beta 0.06 · Correlation with S&P 500 0.02Low beta
Annualized volatility 32% vs. 13% for the S&P 500
Insider Trading
View all →Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
No open-market buys or sells by officers or directors in the last 90 days.
Multi-Quarter Financial Trends
View all quarters →Last 12 quarters · As reported by the company
| Quarter | Revenue ($B) | YoY | Gross Margin | Net Income ($B) | EPS |
|---|---|---|---|---|---|
| FY2026 Q2 | 4.64 | +8.3% | — | 0.36 | 5.98 |
| FY2026 Q1 | 4.50 | +9.6% | — | 0.35 | 5.65 |
| FY2025 Q4 | 4.49 | +9.1% | — | 0.45 | 7.01 |
| FY2025 Q3 | 4.50 | +13.4% | — | 0.37 | 5.86 |
| FY2025 Q2 | 4.28 | +9.6% | — | 0.35 | 5.43 |
| FY2025 Q1 | 4.10 | +6.7% | — | 0.32 | 4.80 |
| FY2024 Q4 | 4.11 | +11.1% | — | 0.33 | 4.94 |
| FY2024 Q3 | 3.96 | +11.2% | — | 0.26 | 3.80 |
| FY2024 Q2 | 3.91 | +10.1% | — | 0.29 | 4.26 |
| FY2024 Q1 | 3.84 | +10.8% | — | 0.26 | 3.82 |
| FY2023 Q4 | 3.70 | +7.4% | — | 0.22 | 3.13 |
| FY2023 Q3 | 3.56 | +6.8% | — | 0.17 | 2.40 |
| Ticker | P/E | Revenue YoY | Gross Margin | 1M | View |
|---|---|---|---|---|---|
| UHS | 7.1 | +8.3% | — | +1.03% | Neutral |
| LLY | 50.2 | +38.6% | 83.9% | +22.51% | Bullish |
| JNJ | 41.3 | +5.9% | 68.1% | +3.20% | Bullish |
| ABBV | 81.4 | +10.2% | 74.7% | +12.73% | Bullish |
| UNH | 23.0 | +0.4% | 88.1% | +10.87% | Bullish |
| MRK | 117.2 | +5.1% | 73.5% | +2.90% | Neutral |
| TMO | 36.4 | +9.1% | — | +3.25% | Neutral |
| AMGN | 28.5 | +9.5% | 72.0% | +10.56% | Bullish |
| GILD | — | +6.8% | 81.1% | +14.51% | Neutral |